Aurobindo Pharma Ltd. — TTAB Proceedings
Aurobindo Pharma Ltd. is a party to 6 TTAB proceedings.
Proceedings
- Proceeding 88359350 — Extensions of Time to Oppose, Terminated (filed 2019-08-14) against Novartis AG as defendant
- Proceeding 91236390 — Oppositions, Terminated (filed 2017-08-29) against Insight Pharmaceuticals LLC as defendant
- Proceeding 91232170 — Oppositions, Terminated (filed 2017-01-10) against The Procter & Gamble Company as defendant
- Proceeding 91231880 — Oppositions, Terminated (filed 2016-12-21) against The Procter & Gamble Company as defendant
- Proceeding 87007459 — Extensions of Time to Oppose, Terminated (filed 2016-09-14) against The Procter & Gamble Company as defendant
- Proceeding 87007364 — Extensions of Time to Oppose, Terminated (filed 2016-09-14) against The Procter & Gamble Company as defendant
Marks in These TTAB Matters
Recent Live Filings
- KALLIGA — Pending, filed 2026-02-10
- ELIMITE — Pending, filed 2025-01-16
- Trademark 98543758 — Pending, filed 2024-05-10
- CYONANZ — Pending, filed 2023-08-09
- EMZAHH — Registered, filed 2023-01-27
- RHUZDAH — Pending, filed 2023-01-27
- ICLEVIA — Pending, filed 2023-01-17
- AFIRMELLE — Pending, filed 2023-01-17
- NYLIA — Registered, filed 2020-03-20
- TRI-LO-MILI — Registered, filed 2019-08-12
- SIMPESSE — Registered, filed 2019-03-27
- AUROVELA — Registered, filed 2019-03-27
- ZUMANDIMINE — Registered, filed 2018-04-21
- INCASSIA — Registered, filed 2016-10-01
- AUROHEALTH — Registered, filed 2016-09-08
Common TTAB Counterparties
- The Procter & Gamble Company — 4 proceedings
- Insight Pharmaceuticals LLC — 1 proceedings
- Novartis AG — 1 proceedings
Recent TTAB Timeline
- 2019-12-11: 88359350 — TERMINATED involving Novartis AG
- 2019-12-11: 88359350 — RELINQUISHMENT ACKNOWLEDGED; APPLICATION RELEASED TO TRADEMARKS involving Novartis AG
- 2019-12-11: 88359350 — P RELINQUISHMENT OF EXT involving Novartis AG
- 2019-11-05: 88359350 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2019-11-05: 88359350 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Novartis AG
- 2019-08-14: 88359350 — EXTENSION OF TIME GRANTED involving Novartis AG
- 2019-08-14: 88359350 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Novartis AG
- 2018-02-27: 91236390 — TERMINATED involving Insight Pharmaceuticals LLC
- 2018-02-27: 91236390 — BOARD'S DECISION: DISMISSED involving Insight Pharmaceuticals LLC
- 2018-02-14: 91236390 — WITHDRAWAL OF OPPOSITION involving Insight Pharmaceuticals LLC
- 2018-02-13: 91236390 — RESPONSE DUE involving Insight Pharmaceuticals LLC
- 2018-02-06: 91236390 — SUSPENDED involving Insight Pharmaceuticals LLC
- 2018-02-06: 91236390 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Insight Pharmaceuticals LLC
- 2018-01-03: 91236390 — SUSPENDED involving Insight Pharmaceuticals LLC
- 2018-01-03: 91236390 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Insight Pharmaceuticals LLC
- 2017-12-21: 91236390 — SUBMITTED ON BRIEF involving Insight Pharmaceuticals LLC
- 2017-12-21: 91236390 — MOT TO AMEND APPLICATION involving Insight Pharmaceuticals LLC
- 2017-11-30: 91236390 — SUSPENDED involving Insight Pharmaceuticals LLC
- 2017-11-30: 91236390 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Insight Pharmaceuticals LLC
- 2017-11-03: 91236390 — SUSPENDED involving Insight Pharmaceuticals LLC
- 2017-11-03: 91236390 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Insight Pharmaceuticals LLC
- 2017-10-05: 91236390 — EXTENSION OF TIME GRANTED involving Insight Pharmaceuticals LLC
- 2017-10-05: 91236390 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Insight Pharmaceuticals LLC
- 2017-08-29: 91236390 — PENDING, INSTITUTED involving Insight Pharmaceuticals LLC
- 2017-08-29: 91236390 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Insight Pharmaceuticals LLC
- 2017-08-29: 91236390 — FILED AND FEE involving Insight Pharmaceuticals LLC
- 2017-04-24: 91232170 — TERMINATED involving The Procter & Gamble Company
- 2017-04-24: 91232170 — BOARD'S DECISION: SUSTAINED involving The Procter & Gamble Company
- 2017-03-30: 91231880 — TERMINATED involving The Procter & Gamble Company
- 2017-03-30: 91231880 — BOARD'S DECISION: SUSTAINED involving The Procter & Gamble Company